Concepedia

Regend Therapeutics (China)

RT

Statistics

Publications

268

Citations

20.5K

Authors

19

Location

Xinghua, China

Regend Therapeutics (China) is a company institution in Xinghua, China known for medicine, cancer immunotherapy, and immunology.

HomepageROR

Top concepts

Publications

268

Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2

bioRxiv (Cold Spring Harbor Laboratory) · 2020 · 763 citations · Full text

, , +12

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial interim results

Changsong Qi, Jifang Gong, Jian Li et al. · Nature Medicine · 2022 · 571 citations · Full text

, , +17

AAV1-hOTOF gene therapy for autosomal recessive deafness 9: a single-arm trial

Jun Lv, Hui Wang, Xiaoting Cheng et al. · The Lancet · 2024 · 325 citations

, , +10

Claudin18.2-specific CAR T cells in gastrointestinal cancers: phase 1 trial final results

Changsong Qi, Chang Liu, Jifang Gong et al. · Nature Medicine · 2024 · 178 citations

, , +13

GPRC5D CAR T cells (OriCAR-017) in patients with relapsed or refractory multiple myeloma (POLARIS): a first-in-human, single-centre, single-arm, phase 1 trial

Mingming Zhang, Guoqing Wei, Linghui Zhou et al. · The Lancet Haematology · 2023 · 159 citations

, , +14

1–5 of 268

Authors

19

  1. DY
    Daijing Yuan

    Regend Therapeutics (China), China

    36 publications · 1.5K citations

    10

    h-index

  2. LM
    Linjie Ma

    Regend Therapeutics (China), China

    178 publications · 164 citations

    6

    h-index

  3. JS
    Jing Shi

    Regend Therapeutics (China), China

    52 publications · 119 citations

    5

    h-index

  4. KL
    Kevin Lynch

    Regend Therapeutics (China), China

    31 publications · 204 citations

    5

    h-index

  5. JH
    Jing Han

    Regend Therapeutics (China), China

    6 publications · 196 citations

    4

    h-index

1–5 of 19